Literature DB >> 28149138

Role of Procalcitonin in Evaluation of the Severity of Acute Cholecystitis.

Yucel Yuzbasioglu1, Hikmet Duymaz2, Ceren Sen Tanrikulu3, Huseyin Cahit Halhalli4, Mirac Ozturk Koc5, Meral Tandoğan6, Figen Coskun7.   

Abstract

OBJECTIVE: The aim of this study is to investigate the relationship between procalcitonin (PCT) level and the severity of acute cholecystitis.
MATERIALS AND METHODS: This study included 200 patients diagnosed with acute cholecystitis. To diagnose and assess the severity of acute cholecystitis; physical examination and abdominal ultrasound findings were evaluated and blood samples were taken to determine white blood cell (WBC) count, erythrocyte sedimentation rate (ESR), and levels of coagulation factors, blood gas, C-reactive protein (CRP) and PCT. Patients were classified into three stages, namely, mild, moderate, and severe, according to the severity of acute cholecystitis using the Tokyo guidelines. The role of PCT level in the assessment of severity of acute cholecystitis and the correlation between the stages and PCT level were statistically analyzed.
RESULTS: Among patients with acute cholecystitis, 110 (55%) were classified as mild, 61 (30.5%) as moderate, and 29 (14.5%) as severe. Leukocytosis or leukopenia was positive in 48.5%, ESR elevation was found in 72.5%, CRP positivity in 55.5%, PCT elevation in 27%, and positive findings of ultrasonographic imaging in 54.5% of the patients. Serum WBC count, ESR, and CRP and PCT levels increased as the severity of disease increased (p<0.05). PCT could discriminate grade I from grade II-III with 95.45% sensitivity and 46.67% specificity at the best cut-off value of ≤0.52 (p<0.001). PCT could also discriminate grade III from grade I-II with 72.4% sensitivity and 90.06% specificity at the best cut-off value of >0.8 (p<0.001).
CONCLUSION: PCT level may be considered to be a parameter that could be added to the assessment of the severity of acute cholecystitis in the Tokyo guidelines, although further studies are needed to support our findings.

Entities:  

Keywords:  Procalcitonin; acute cholecystitis; severity of illness index

Year:  2016        PMID: 28149138      PMCID: PMC5268595          DOI: 10.5152/eurasianmedj.2016.0052

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  18 in total

Review 1.  Clinical applications of C-reactive protein in pediatrics.

Authors:  D L Jaye; K B Waites
Journal:  Pediatr Infect Dis J       Date:  1997-08       Impact factor: 2.129

Review 2.  Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors.

Authors:  K L Becker; E S Nylén; J C White; B Müller; R H Snider
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

3.  Does the correlation of acute cholecystitis on ultrasound and at surgery reflect a mirror image?

Authors:  Juliane Bingener; Wayne H Schwesinger; Shailandra Chopra; Melanie L Richards; Kenneth R Sirinek
Journal:  Am J Surg       Date:  2004-12       Impact factor: 2.565

4.  C-reactive protein has a better discriminative power than white cell count in the diagnosis of acute cholecystitis.

Authors:  Andrei M Beliaev; Roger J Marshall; Michael Booth
Journal:  J Surg Res       Date:  2015-05-09       Impact factor: 2.192

5.  [Personal experience in 71 consecutive patients with acute cholecystitis].

Authors:  A Pinto; S Romano; W Del Vecchio; L Romano; F Pinto; M Scaglione; S Cappabianca; R Grassi
Journal:  Radiol Med       Date:  2000 Jan-Feb       Impact factor: 3.469

Review 6.  [Erythrocyte sedimentation rate--more than an old fashion?].

Authors:  W H Reinhart
Journal:  Ther Umsch       Date:  2006-01

7.  Acute cholecystitis--room for improvement?

Authors:  I C Cameron; C Chadwick; J Phillips; A G Johnson
Journal:  Ann R Coll Surg Engl       Date:  2002-01       Impact factor: 1.891

8.  Is a drain required after laparoscopic cholecystectomy?

Authors:  Ahmet Gurer; Ersin Gurkan Dumlu; Erol Dikili; Gulten Kiyak; Nuraydin Ozlem
Journal:  Eurasian J Med       Date:  2013-10

9.  Results of the Tokyo Consensus Meeting Tokyo Guidelines.

Authors:  Toshihiko Mayumi; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Masahiro Yoshida; Miho Sekimoto; Fumihiko Miura; Keita Wada; Masahiko Hirota; Yuichi Yamashita; Masato Nagino; Toshio Tsuyuguchi; Atsushi Tanaka; Harumi Gomi; Henry A Pitt
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

10.  Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.

Authors:  Junyan Qu; Xiaoju L; Yanbin Liu; Xiaohui Wang
Journal:  Indian J Med Res       Date:  2015-03       Impact factor: 2.375

View more
  5 in total

1.  Validity of the Glasgow prognostic score and modified systemic inflamma-tion score in predicting complicated cholecystitis.

Authors:  D O Karakaş; M Yeşiltaş
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

Review 2.  Sepsis and Septic Shock: Current Treatment Strategies and New Approaches.

Authors:  Gizem Polat; Rustem Anil Ugan; Elif Cadirci; Zekai Halici
Journal:  Eurasian J Med       Date:  2017-02

3.  Role of procalcitonin as a predictor in difficult laparoscopic cholecystectomy for acute cholecystitis case: A retrospective study based on the TG18 criteria.

Authors:  Tianchong Wu; Minjun Luo; Yuehua Guo; Jiangang Bi; Yusheng Guo; Shiyun Bao
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

4.  Can serum procalcitonin levels be useful in predicting spontaneous ureteral stone passage?

Authors:  Nusret Can Cilesiz; Arif Ozkan; Arif Kalkanli; Ali Eroglu; Cem Tuğrul Gezmis; Berkan Simsek; Burak Arslan
Journal:  BMC Urol       Date:  2020-04-19       Impact factor: 2.264

5.  Plasma Procalcitonin Is Useful for Predicting the Severity of Acute Cholecystitis.

Authors:  Saben Sakalar; Engin Ozakın; Arif Alper Cevik; Nurdan Acar; Serkan Dogan; Filiz Baloglu Kaya; Taylan Kara
Journal:  Emerg Med Int       Date:  2020-01-14       Impact factor: 1.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.